To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

Early analgesia improved with two-dose perioperative IV dexamethasone in total knee arthroplasty

Download
Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Ace Report Cover
November 2018

Early analgesia improved with two-dose perioperative IV dexamethasone in total knee arthroplasty

Vol: 7| Issue: 11| Number:17| ISSN#: 2564-2537
Study Type:Randomized Trial
OE Level Evidence:2
Journal Level of Evidence:1

Two doses of low-dose perioperative dexamethasone improve the clinical outcome after total knee arthroplasty: a randomized controlled study

Knee Surg Sports Traumatol Arthrosc. 2018 May;26(5):1549-1556

Contributing Authors:
J Ma FX Pei Q Huang ZY Huang B Xu SY Zhang

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

108 patients scheduled for total knee arthroplasty were randomized to two perioperative doses of either intravenous dexamethasone 10mg or intravenous saline. Patients were followed up over the first three days postoperatively. Pain scores at rest and on movement were significantly lower in the IV dexamethasone group compared to the control group at 24 hours, but not 48 or 72 hours. Additionally, r...

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.

Learn about our AI Driven
High Impact Search Feature

High Impact Icon

Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.

Continue